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The following paper was presented in part during the 1 s t International 
Influenza Symposium organized in Athens, on February 23 r c* 2007, 
in the amphitheatre of the Foundation of Biomedical Research of the 
Academy of Athens (FBRAA), under the auspices of the Ministry of 
Rural Deve lopment and Food, the FBRAA and the Hel lenic 
Veterinary Medical Society. 
Η εργασία αυτή ανακοινώθηκε στο 1° Διεθνές Συμπόσιο για τη 
Γρίπη που διοργανώθηκε στις 23 Φεβρουαρίου 2007 στο αμφιθέ­
ατρο του Ιδρύματος Ιατροβιολογικών Ερευνών της Ακαδημίας Αθη­
ν ώ ν από την Ελληνική Κτηνιατρική Εταιρεία, σε συνεργασία με το 
Ί δ ρ υ μ α Ιατροβιολογικών Ερευνών της Ακαδημίας Αθηνών και υπό 
την αιγίδα του Υπουργείου Αγροτικής Ανάπτυξης και Τροφίμων. 
Πανδημία γρίπης του ανθρώπου 
Μύθος και πραγματικότητα 
Human influenza pandemics 
Myth and reality 
Tsiodras S.1: Tsiodras S.1" 
Π Ε Ρ Ι Λ Η Ψ Η . Η παρούσα εργασία προσπαθεί να ρίξει φ ω ς σε 
συγκεκριμένα ερωτήματα και λανθασμένες πεποιθήσεις, σχετικές 
με την εποχική, την πανδημική και τη γρίπη των πτηνών, εστιάζο­
ντας κυρίως σε θέματα που αφορούν στην πανδημική γρίπη. Ανά­
μεσα στην εποχική γρίπη, την πανδημική και αυτή των πτηνών 
υπάρχουν σημαντικές ομοιότητες, αλλά και διαφορές. Ιστορικά, 
στοιχεία από παλαιότερες πανδημίες συνεισέφεραν τόσο στην αξιο­
λόγηση του κοινωνικού, οικονομικού και πολιτικού αντίκτυπου όσο 
και στην προετοιμασία για μία μελλοντική πανδημία στον άνθρω­
πο. Τ α στελέχη που κυκλοφορούν τώρα, όπως αυτό της γρίπης των 
πτηνών Η 5 Ν 1 , απαρτίζουν κίνδυνο για τη δημόσια υγεία για μία 
μελλοντική πανδημία. Λαμβάνοντας υπόψη την κλινική εικόνα, 
φαίνεται ότι σε περίπτωση που το νόσημα προκαλέσει πανδημία, 
ο βαθμός θνησιμότητας θα είναι υψηλός, ιδιαίτερα σε ευπαθείς 
πληθυσμούς. Επιπλέον, φαίνεται ότι η ανάγκη για διαγνωστικό 
έλεγχο επιβεβαίωσης θα ελαττώνεται, καθώς η πανδημία θα βρί­
σκεται σε εξέλιξη, ενώ ένας αντιϊκός παράγοντας δεν θα είναι αρ­
κετός. Παράλληλα, στην επιστημονική κοινότητα δεν υπάρχει ομο­
φωνία σχετικά με την επιτυχία ενός Η 5 Ν 1 εμβολίου πριν την παν­
δημία. Έτοιμα προγράμματα σε περίπτωση πανδημίας, τα οποία θα 
επιληφθούν λεπτών θεμάτων όπως είναι τα αντιϊκά φάρμακα, οι 
εμβολιασμοί πριν την εμφάνιση μιας πανδημίας και τα μη φαρ­
μακευτικά μέτρα, είναι απαραίτητο να σχεδιαστούν και να ελεγ­
χθούν στην πράξη, ώστε να διαπιστωθούν τα ενδεχόμενα προβλή­
ματα εφαρμογής τους. 
Λέξεις ευρετηρίασης: πανδημία, γρίπη, μύθος, πραγματικότητα 
A B S T R A C T . This paper attempts to shed light in certain 
questions and false beliefs about seasonal, avian and pandemic 
influenza, mainly focusing on issues surrounding pandemic 
influenza. Important similarities and differences exist between 
seasonal, avian and pandemic influenza. Historical lessons from old 
pandemics help in recognizing their significant social, economical 
and political impact and guide the current preparedness for a future 
human pandemic. Currendy circulating strains, such as the avian 
influenza H5N1 strain constitute a danger to public health and have 
significant pandemic potential. Regarding clinical characteristics it 
appears that disease associated with a pandemic will have a high case 
fatality rate especially in vulnerable populations. Furthermore, the 
need for confirmatory diagnostic testing will likely diminish as a 
pandemic progresses. With regards to management stockpiling one 
antiviral agent will probably not be enough. No uniform scientific 
conclusion about the success of a prepandemic H 5 N 1 vaccine has 
been reached yet. Complete pandemic plans that address subde 
issues surrounding stockpiling antivirals and prepandemic vaccines 
as well as non-pharmaceutical measures need to be ready and to be 
tested in practice in order to identify problems with implementation 
and gaps in preparedness. 
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INTRODUCTION 
Important differences exist between seasonal, avian 
and pandemic influenza. 
A lot of lay people, but also health professionals 
still do not recognize the differences between the three 
influenzas and why they are discussed together. The 
term seasonal influenza refers to the annual seasonal 
increases in influenza rates (during the cold months of 
the winter for the Northern hemisphere season). The 
term "avian influenza" is used as an ecological 
classification term and is non-specific. The current 
H5N1 avian strain, causing the large multiple outbreaks 
predominantly in Southeast Asia, is a type A influenza 
strain that affects domestic or wild birds and other avian 
species. Any similar influenza A type falls under the 
same term. Pandemic influenza is rarely seen and for 
molecular and genetic reasons can only be caused by 
type A influenza viruses that are also responsible for 
avian influenza. The current fear is that the circulating 
avian influenza A/H5N1 strain will evolve into a form 
that is easily transmitted from person to person and 
will give rise to the next human influenza pandemic. In 
this paper we attempt to clear certain false beliefs about 
seasonal, avian and pandemic influenza as those pertain 
to the pathophysiology, clinical picture, diagnosis, 
treatment and prevention issues. Due to its importance 
the focus of this effort will especially be pandemic 
influenza. 
METHODS 
ST independently performed the literature search. 
The following terms were used in searches of the 
PubMed database: "influenza", "avian influenza", 
"influenza A", "H5N1", "seasonal influenza", "pandemic 
influenza" and "pandemic". Using a web search engine 
(Google) we screened the same terms in conjunction 
with the terms "myth" and "realities". All articles 
identified were reviewed with an emphasis on major 
reports that included the search terms and review articles 
concerning the three influenzas from major journals 
(e.g. New England Journal of Medicine, Science, Nature, 
Nature Medicine, Lancet, JAMA, PN AS). In addition, 
broadcasts and reports from major scientific and 
humanitarian organizations (e.g. WHO, United States 
CDC, European CDC, European Commission, FAO) 
and major media organizations (e.g. CNN, BBC, 
Reuters, Skynews, NY times) were screened for 1 year 
prior to this report to identify the major areas of interest 
about the three influenzas that were publicized and 
identify areas with knowledge gaps in the general public. 
We screened articles related to the initially identified 
publications to expand our data sources. 
RESULTS 
Several knowledge gaps were identified helping in 
establishing a list of ten myths and realities pertaining 
to seasonal, avian and pandemic influenza (Table 1). 
1) Reality: Huge genetic diversity exists for all 
influenza viruses 
The influenza virus genome consists of ten genes 
encoding for eight structural and two non-structural 
proteins. Among the eight structural proteins the most 
well known are the two surface glycoproteins namely 
hemagglutinin (HA) and neuraminidase (NA). These 
proteins serve as an envelope for the virus and are 
evenly distributed over the virion surface, forming 
characteristic spikes. Variations in these proteins define 
an influenza A virus subtype, e.g. influenza A/H5N1. So 
far 16 different hemaglutinin (HA) antigens (HI to 
HI6) and nine different neuraminidase (NA) antigens 
(Nl to N9) have been characterized for influenza A. 
The new HA type is type H16 that was isolated from 
black-headed gulls in Sweden and the Netherlands in 
1999 (Fouchier et al. 2005). Genetic reassortment of two 
different influenza viruses infecting the same cell may 
occur resulting in strains that could be markedly 
different from the original virus (Voyles 2002). Major 
genetic reassortment events are a prerequisite for a 
pandemic and are called a genetic shift. A genetic shift 
can actually occur between human and animal strains as 
was the case with the 1957 and 1968 pandemic influenza 
strains. Once a novel influenza strain emerges it should 
have certain characteristics in order to cause a 
Table 1. Ten myths and realities about pandemic influenza as 
they relate to preparedness 
Realities 
1. Huge genetic diversity exists for all influenza viruses 
2. Wild birds are the natural host for Influenza A viruses 
3. At least 10 pandemics have been recorded in humans 
in the past 300 years 
4. Only HI, H2 and H3 are known to have caused 
epidemics and pandemics in humans 
5. The influenza A/H5N1 strain that is currently 
circulating is considered to have the greatest 
potential for a human pandemic 
Myths 
6. Dogs are not affected by influenza 
7. Clinical symptoms differ between seasonal, avian 
and pandemic influenza 
8. Confirmatory laboratory testing is necessary during 
a pandemic 
9. The pandemic strain will be susceptible to oseltamivir, 
thus stockpiling one antiviral will suffice 
10. H5N1 vaccines should be stockpiled according to WHO 
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pandemic. It has to be: a) highly pathogenic for humans; 
b) easily transmitted from person to person; and c) 
genetically unique so that it faces a lack of immunity at 
the population level. On the other hand, small genetic 
changes of the HA and NA proteins occur in circulating 
influenza viruses continuously every year, are called a 
genetic drift and form the basis for the seasonal 
influenza outbreaks. These changes direct the annual 
development of new influenza vaccines. 
2) Reality: wild birds are the natural host for 
Influenza A viruses 
Inlfuenza A viruses can infect humans, pigs, horses, 
seals, whales and other animals, but wild birds are the 
most important natural host. Most pandemics have 
started in countries where situations favor an intimate 
association of people with animals (Beveridge 1993). 
3) Myth: Dogs are not affected by influenza 
Importantly influenza A viruses recently have been 
shown to be able to infect animals not traditionally 
known to be affected by influenza, such as felids e.g. 
cats, leopards and tigers (Keawcharoen et al. 2004; 
Webster and Govorkova 2006) as is the case with the 
currently circulating H5N1 strains and dogs as is the 
case with H3N8 influenza A, a virus strain that is usually 
associated with infection in horses (Crawford et al. 2005). 
4) Reality: At least 10 pandemics have been 
recorded in humans in the past 300 years 
Although it seems that influenza has been around 
for thousands of years and some of the earliest reports 
date back to Hippocrates, little is known about true 
influenza pandemics in the last 300 years. However, 
starting from the 16th century and going forward, three 
to four pandemics occur every century over the last 300 
years reaching a total figure of at least ten pandemics. 
During this time, an interval from 10 to 49 years was 
observed with an average of 24 years between each 
pandemic and the one following. One of the first well 
described influenza pandemics that was associated with 
high death rates is reported in the year 1580, starting in 
Asia and rapidly spreading to Africa, Europe and the 
Americas. This pandemic reportedly killed 10% of the 
population of Rome and left large cities depopulated 
(Beveridge 1978). During the 18th and 19th century at 
least seven pandemics occurred. The last pandemic of 
the 19th century occurred during 1889-90 and was 
known as the Russian Flu. It is estimated that it killed 
about 1 million people, a figure similar to the 1957 and 
1968 20th century pandemics. 
5) Reality: Only HI, H2 and H3 are known to have 
caused epidemics and pandemics in humans 
The Spanish pandemic of 1918 was due to an H1N1 
strain. The Asian pandemic in 1957 was due to an H2N2 
strain, while the Hong-Kong 1968 strain was a H3N2. 
Currently circulating human influenza A viruses are 
of H1N1, H1N2 and H3N2 subtype and are strains 
included in the seasonal influenza vaccine. 
6) Reality: The influenza A/H5N1 strain that is 
currently circulating is considered to have the 
greatest potential for a human pandemic 
An influenza strain, in order to be considered a good 
candidate to cause a pandemic besides causing human 
disease, it should be easily transmitted in a population 
that has never been exposed to a similar strain, thus 
lacking specific immunity. The H5N1 strain fulfills all 
these criteria except for the efficient transmission and 
thus is considered the best candidate for a human 
pandemic in the immediate future. Moreover, H5N1 is 
associated with high case fatality rates and is 
continuously evolving. Thus it could become easily 
transmissible between humans either through genetic 
reassortment or via gradual adaptation. Influenza 
A/H5N1 defines the current pandemic alert level as 
phase 3 according to the WHO Global Influenza 
Preparedness Plan. Besides influenza strains of the H5 
subtype, H7 subtypes are also considered of great 
concern since the vast majority of the population, as 
never been exposed to them. 
7) Myth: Clinical symptoms differ between seasonal, 
avian and pandemic influenza 
Influenza like illness is characterized by cough and 
fever together with symptoms from the upper respiratory 
tract and other systemic symptoms, e.g. sore throat, 
headache and myalgias. All influenza strains affecting 
humans present with the same clinical picture. It is only 
the degree of severity that changes with the highly 
pathogenic pandemic strains. These strains are associated 
with high case fatality rates due to respiratory distress. A 
highly aggressive bronchopneumonia as well as rapidly 
evolving acute respiratory distress were characteristics 
of the 1918 clinical picture (Morens and Fauci 2007). Of 
note a pandemic may have a greater impact on vulnerable 
populations, such as children (H5N1 being the best 
example of a current strain) and pregnant women as was 
the case with 1918 pandemic. A meta-analysis showed 
case fatality rates as high as 70% in affected pregnant 
women during the 1918 pandemic (Barry). 
8) Myth: Confirmatory laboratory testing is 
necessary during a pandemic 
Significant advances in the laboratory diagnosis of 
influenza include the evolution of rapid antigen testing 
and molecular techniques in addition to the gold 
standard of culture. Serologic tests are only used to 
ΠΕΡΙΟΔΙΚΟ ΤΗΣ ΕΛΛΗΝΙΚΗΣ ΚΤΗΝΙΑΤΡΙΚΗΣ ΕΤΑΙΡΕΙΑΣ 2007,58(3) 
JOURNAL OF THE HELLENIC VETERINARY MEDICAL SOCIETY 2007,58(3) 
http://epublishing.ekt.gr | e-Publisher: EKT | Downloaded at 21/02/2020 00:00:36 |
206 TSIODRAS S. 
retrospectively diagnose infection and for epidemio­
logical purposes. During a pandemic it will be difficult to 
offer specific recommendations about laboratory testing. 
These will depend on the level of the influenza activity 
in the community and the severity of the clinical picture. 
In situation with high attack rates and severe disease 
the clinical picture alone will suffice to diagnose the 
infection. It is expected that as a pandemic advances to 
severe patterns of disease characterized by acute respira­
tory distress, the need for confirmatory diagnostic testing 
will diminish and the treatment will be empirically 
instituted. Nevertheless, other important factors include 
the availability of resources for testing, the co-circulation 
of various other influenza strains in the community, the 
positive and negative predictive values of the laboratory 
techniques (Weinberg 2005) and surge capacity issues 
with antivirals. 
9) Myth: The pandemic strain will be susceptible to 
oseltamivir, thus stockpiling one antiviral will suffice 
From significant modeling work it has been 
estimated that an antiviral stockpile covering 20% to 
25% of the population can be used until the prepared­
ness of an effective vaccine and would lead to a 50% to 
77% reduction in hospitalizations (Gani et al. 2005). 
Neuraminidase inhibitors and especially oseltamivir are 
currently being considered as the best monotherapeutic 
option in the event of a possible influenza pandemic. 
This is due to misconceptions regarding their safety and 
resistance profile when compared to ion channel 
inhibitors like amantadine. However, neurmaninidase 
inhibitors are associated with important side effects and 
resistance is emerging even in the recent H5N1 strains 
(Tsiodras et al. 2007). The truth is that no single anti-
influenza drug can be seen as a panacea and antivirals 
should be seen as a part of a wider package of measures 
and options to control the potential spread of pandemic 
influenza, including of course the most important 
measure that is effective vaccination. In particular and 
as suggested by recent research (Tsiodras et al. 2007), 
there may be a potential role for combination therapy, 
may be an appropriate solution for a pandemic in order 
to minimize the development of resistance to antivirals. 
Nevertheless, there is a need for an improved evidence 
base regarding the exact role for ion channel inhibitors, 
since no one knows what the susceptibility pattern of a 
pandemic influenza strain will be. 
10) Myth: H5N1 vaccines should be stockpiled 
according to WHO 
An effective pandemic vaccine is considered as the 
most significant measure for controlling an influenza 
pandemic. It has been estimated that it will take at least 
4 to 6 months to develop a vaccine. Approximately 200-
300 mil doses of the seasonal trivalent vaccine are 
produced annually in nine specific developed countries 
with vaccine production capacity (Fedson 2003). Thus 
the use of these traditional resources and procedures 
will not be enough to respond to the crisis of an influenza 
pandemic when the global vaccine demand will rise to 
significantly higher levels. Several steps are introduced to 
address this problem. These include, but are not limited 
to the use of newer molecular techniques to prepare 
seed strains (Luke and Subbarao 2006; Palese 2006), the 
development of prepandemic vaccines, such as those 
targeting the H5N1 clades and subclades (Treanor et al. 
2006), as well as procedures for global vaccine 
registration and the negotiation of political agreements 
that will ensure the adequate production and equitable 
distribution of pandemic vaccine throughout the world 
(Fedson 2005). Recent research suggests that an H5N1 
prepandemic vaccine may prime the human immune 
system, thus making one instead of two doses of a 
pandemic vaccine efficacious during a pandemic (Monto 
2006). Very recently WHO issued a statement about the 
progress with the development of pandemic influenza 
vaccines indicating that at least 10 countries are 
developing influenza vaccines targeting H5N1 strains 
and some of them against other potential pandemic avian 
strains, such as H9N2(WHO 2007). Despite the fact that 
some countries, such as the US, have already agreed to 
stockpile prepandemic H5N1 vaccines, the WHO has 
recently stated that it still not prudent to make global 
recommendations in favor of stockpiling H5N1 vaccines 
due to many scientific uncertainties (WHO 2006). 
Certainly, such a position may change in the near future. 
DISCUSSION 
This work identified several points that need 
clarification with regards to seasonal, avian and 
pandemic influenza. These included historical lessons 
showing that influenza pandemics are not new and there 
is a lot one can learn from studying old pandemics, 
especially the most recent ones. From these lessons it 
appears that a pandemic is expected to have significant 
social, economical and political impact. Thus complete 
preparedness plans should be available and get tested 
for issues with implementation in all countries around 
the world. 
In addition, this report identified evidence that 
currently circulating strains, such as the avian influenza 
H5N1 strain, constitute a danger to public health and 
have significant pandemic potential. This is due to 
specific characteristics, such as the lack of general 
population immunity and the ability to cause human 
disease with high case-fatality rates. However, it is 
important to understand that potentially any strain 
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could evolve to become a pandemic strain, such as 
strains harboring hemaglutinins of the H7 or H9 
subtype, either through genetic reassortment or gradual 
adaptation to the human host. 
Further, as the global community actively prepares 
for the next pandemic and as evidenced from the various 
pandemic plans reviewed, decision makers in various 
countries have not conclusively decided yet on how to 
approach sensitive issues in pandemic preparedness in 
a harmonized fashion. Thus stockpiling antivirals and 
prepandemic vaccines is not uniformly managed and 
depends upon the country examined and the available 
local and national resources. In addition to vaccines 
and antiviral agents, data assessing the effectiveness of 
non-pharmaceutical interventions need to be further 
examined. Strategies, such as the wide implementation 
of handwashing and respiratory hygiene/cough 
etiquette, as well as more in more extreme cases 
isolation at home and quarantine together with social 
distancing measures have been considered (WHO), but 
are not specifically addressed in most pandemic plans 
with few exceptions (CDC 2007). 
Several complex issues will arise during a pandemic 
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